Galenica | Sustainability Performance
Operates in pharmaceutical distribution, retail, and healthcare services.
1927
Switzerland
5,001 - 10,000 employees
Pharmaceuticals
$1B - 10B in revenue
$100M - 500M in profitability
Submit or report inaccurate dataDownload Company InsightsⓘBy downloading this report, you'll receive the most insightful and detailed analysis of the company's sustainability performance, compared to its peers. It includes key industry trends, carbon and energy intensity, nature impact, social metrics, and an in-depth look at key risks and controversies.
Sustainability Ranking & Industry Benchmark
#148
Overallⓘ#10
in Switzerlandⓘ#4
in PharmaceuticalsⓘSustainability Maturity
ⓘSustainability Intent
ⓘOverview
Environmental
Carbon emissionsEnergy consumptionWaste ManagementWater ManagementSocial
Diversity and InclusionFinancial Data
Business performanceCapital & innovationAnalyst projections
Leading
Aligned
Laggard
Intensity
Greenhouse gas intensity (Scope 1, 2, 3)(tCO₂e /$M)
Energy consumption (direct) intensity (MWh /$M)
Waste generation intensity (tonnes /$M)
Industry Benchmark
80.7
B/M 312.2
8.9
B/M 42.0
0.7
B/M 0.4
Powered by illuminem and GIST Impact
Controversy level
- Galenica AG, Swiss pharmaceutical distribution/retail major, has faced sustained Swiss Swissmedic enforcement scrutiny over alleged inadequate disclosure of pharmacy retail customer service quality at multiple Galenica retail operations, plus periodic class actions over alleged inadequate disclosure of Swiss healthcare market normalization affecting Swiss institutional shareholders.
Sustainability employees
ⓘWe follow the strictest rules to ensure compliance with all the relevant data protection laws, including GDPR. Click here for our Privacy Policy.Total sustainability employees
11+
ⓘThis value represents the estimated number of employees in a company with sustainability-related roles or job titles, as determined by Illuminem using publicly available data.